MG
DXCM icon

Mather Group’s DexCom DXCM Stock Holding History

Mather Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Sell
441
-587
-57% -$39.1K ﹤0.01% 1240
2026
Q1 		$64.6K Buy
+1,028
New +$71.6K ﹤0.01% 1000
2025
Q4 		– Sell
-681
Closed -$45.8K – 919
2025
Q3 		$45.8K Buy
+681
New +$53.9K ﹤0.01% 923
2025
Q2 		– Sell
-1,109
Closed -$75.7K – 915
2025
Q1 		$75.7K Buy
1,109
+638
+135% +$52.1K ﹤0.01% 821
2024
Q4 		$36.6K Buy
471
+59
+14% +$4.37K ﹤0.01% 936
2024
Q3 		$27.6K Sell
412
-851
-67% -$69.9K ﹤0.01% 996
2024
Q2 		$175K Buy
1,263
+378
+43% +$47.8K ﹤0.01% 648
2024
Q1 		$110K Buy
+885
New +$111K ﹤0.01% 679
2022
Q1 		– Sell
-2,136
Closed -$287K – 453
2021
Q4 		$287K Buy
+2,136
New +$307K 0.01% 304

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mather Group's DXCM Position: Q2 2026 in Review

Mather Group reduced its DexCom (DXCM) stake by 57% in Q2 2026, selling an estimated $39.1K and leaving 441 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Mather Group first reported a position in DXCM in Q4 2021 and has held it in 9 quarters since. The position peaked at $287K in Q4 2021. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Mather Group held 441 shares of DexCom worth $29.7K as of Q2 2026.
  • Mather Group sold 587 DexCom shares in Q2 2026, an estimated $39.1K.
  • DexCom made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1240 holding.
  • Mather Group first reported a position in DexCom in Q4 2021 and has held it in 9 quarters since.
  • Mather Group's DexCom position peaked at $287K in Q4 2021.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.